The global Nuclear Medicine & Radiopharmaceutic market size is expected to reach US$ 13380 million by 2029, growing at a CAGR of 8.6% from 2023 to 2029.

Nuclear Medicine & Radiopharmaceutic - Market

The market is mainly driven by the significant applications of Nuclear Medicine & Radiopharmaceutic in various end use industries. The expanding demands from the Diagnostic and Therapeutic, are propelling Nuclear Medicine & Radiopharmaceutic market. Tc-99, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the I-123/131 segment is estimated at % CAGR for the next seven-year period.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nuclear Medicine & Radiopharmaceutic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Nuclear Medicine & Radiopharmaceutic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Nuclear Medicine & Radiopharmaceutic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nuclear Medicine & Radiopharmaceutic sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Nuclear Medicine & Radiopharmaceutic covered in this report include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Jubilant Pharma, Nordion, Eli Lilly and SIEMENS, etc.

The global Nuclear Medicine & Radiopharmaceutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

GE Healthcare

Bracco Imaging

Mallinckrodt

Lantheus Medical Imaging

Bayer

Jubilant Pharma

Nordion

Eli Lilly

SIEMENS

China Isotope & Radiation

Yantai Dongcheng Biochemicals

Scope of Nuclear Medicine & Radiopharmaceutic - Market Report

Report Metric	Details
Report Name	Nuclear Medicine & Radiopharmaceutic - Market
Forecasted market size in 2029	US$ 13380 million
CAGR	8.6%
Forecasted years	2023 - 2029
Global Nuclear Medicine & Radiopharmaceutic market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nuclear Medicine & Radiopharmaceutic market, Segment by Type:	Tc-99 I-123/131 In-111 Xe-133 Th-201 Ga-67 Other
Global Nuclear Medicine & Radiopharmaceutic market, by Application	Diagnostic Therapeutic
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Nuclear Medicine & Radiopharmaceutic manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nuclear Medicine & Radiopharmaceutic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Nuclear Medicine & Radiopharmaceutic - Market size in 2029?

Ans: The Nuclear Medicine & Radiopharmaceutic - Market size in 2029 will be US$ 13380 million.

What are the Application segmentation covered in the Nuclear Medicine & Radiopharmaceutic - Market report?

Ans: The Applications covered in the Nuclear Medicine & Radiopharmaceutic - Market report are Diagnostic, Therapeutic

What are the Type segmentation covered in the Nuclear Medicine & Radiopharmaceutic - Market report?

Ans: The Types covered in the Nuclear Medicine & Radiopharmaceutic - Market report are Tc-99, I-123/131, In-111, Xe-133, Th-201, Ga-67, Other

1 Nuclear Medicine & Radiopharmaceutic Market Overview

1.1 Nuclear Medicine & Radiopharmaceutic Product Overview

1.2 Nuclear Medicine & Radiopharmaceutic Market Segment by Type

1.2.1 Tc-99

1.2.2 I-123/131

1.2.3 In-111

1.2.4 Xe-133

1.2.5 Th-201

1.2.6 Ga-67

1.2.7 Other

1.3 Global Nuclear Medicine & Radiopharmaceutic Market Size by Type

1.3.1 Global Nuclear Medicine & Radiopharmaceutic Market Size Overview by Type (2018-2029)

1.3.2 Global Nuclear Medicine & Radiopharmaceutic Historic Market Size Review by Type (2018-2023)

1.3.3 Global Nuclear Medicine & Radiopharmaceutic Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Type (2018-2023)

1.4.2 Europe Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Type (2018-2023)

2 Global Nuclear Medicine & Radiopharmaceutic Market Competition by Company

2.1 Global Top Players by Nuclear Medicine & Radiopharmaceutic Sales (2018-2023)

2.2 Global Top Players by Nuclear Medicine & Radiopharmaceutic Revenue (2018-2023)

2.3 Global Top Players by Nuclear Medicine & Radiopharmaceutic Price (2018-2023)

2.4 Global Top Manufacturers Nuclear Medicine & Radiopharmaceutic Manufacturing Base Distribution, Sales Area, Product Type

2.5 Nuclear Medicine & Radiopharmaceutic Market Competitive Situation and Trends

2.5.1 Nuclear Medicine & Radiopharmaceutic Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Nuclear Medicine & Radiopharmaceutic Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine & Radiopharmaceutic as of 2022)

2.7 Date of Key Manufacturers Enter into Nuclear Medicine & Radiopharmaceutic Market

2.8 Key Manufacturers Nuclear Medicine & Radiopharmaceutic Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Nuclear Medicine & Radiopharmaceutic Status and Outlook by Region

3.1 Global Nuclear Medicine & Radiopharmaceutic Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Nuclear Medicine & Radiopharmaceutic Historic Market Size by Region

3.2.1 Global Nuclear Medicine & Radiopharmaceutic Sales in Volume by Region (2018-2023)

3.2.2 Global Nuclear Medicine & Radiopharmaceutic Sales in Value by Region (2018-2023)

3.2.3 Global Nuclear Medicine & Radiopharmaceutic Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Nuclear Medicine & Radiopharmaceutic Forecasted Market Size by Region

3.3.1 Global Nuclear Medicine & Radiopharmaceutic Sales in Volume by Region (2024-2029)

3.3.2 Global Nuclear Medicine & Radiopharmaceutic Sales in Value by Region (2024-2029)

3.3.3 Global Nuclear Medicine & Radiopharmaceutic Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Nuclear Medicine & Radiopharmaceutic by Application

4.1 Nuclear Medicine & Radiopharmaceutic Market Segment by Application

4.1.1 Diagnostic

4.1.2 Therapeutic

4.2 Global Nuclear Medicine & Radiopharmaceutic Market Size by Application

4.2.1 Global Nuclear Medicine & Radiopharmaceutic Market Size Overview by Application (2018-2029)

4.2.2 Global Nuclear Medicine & Radiopharmaceutic Historic Market Size Review by Application (2018-2023)

4.2.3 Global Nuclear Medicine & Radiopharmaceutic Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Application (2018-2023)

4.3.2 Europe Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales Breakdown by Application (2018-2023)

5 North America Nuclear Medicine & Radiopharmaceutic by Country

5.1 North America Nuclear Medicine & Radiopharmaceutic Historic Market Size by Country

5.1.1 North America Nuclear Medicine & Radiopharmaceutic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Nuclear Medicine & Radiopharmaceutic Sales in Volume by Country (2018-2023)

5.1.3 North America Nuclear Medicine & Radiopharmaceutic Sales in Value by Country (2018-2023)

5.2 North America Nuclear Medicine & Radiopharmaceutic Forecasted Market Size by Country

5.2.1 North America Nuclear Medicine & Radiopharmaceutic Sales in Volume by Country (2024-2029)

5.2.2 North America Nuclear Medicine & Radiopharmaceutic Sales in Value by Country (2024-2029)

6 Europe Nuclear Medicine & Radiopharmaceutic by Country

6.1 Europe Nuclear Medicine & Radiopharmaceutic Historic Market Size by Country

6.1.1 Europe Nuclear Medicine & Radiopharmaceutic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Nuclear Medicine & Radiopharmaceutic Sales in Volume by Country (2018-2023)

6.1.3 Europe Nuclear Medicine & Radiopharmaceutic Sales in Value by Country (2018-2023)

6.2 Europe Nuclear Medicine & Radiopharmaceutic Forecasted Market Size by Country

6.2.1 Europe Nuclear Medicine & Radiopharmaceutic Sales in Volume by Country (2024-2029)

6.2.2 Europe Nuclear Medicine & Radiopharmaceutic Sales in Value by Country (2024-2029)

7 Asia-Pacific Nuclear Medicine & Radiopharmaceutic by Region

7.1 Asia-Pacific Nuclear Medicine & Radiopharmaceutic Historic Market Size by Region

7.1.1 Asia-Pacific Nuclear Medicine & Radiopharmaceutic Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Nuclear Medicine & Radiopharmaceutic Forecasted Market Size by Region

7.2.1 Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales in Value by Region (2024-2029)

8 Latin America Nuclear Medicine & Radiopharmaceutic by Country

8.1 Latin America Nuclear Medicine & Radiopharmaceutic Historic Market Size by Country

8.1.1 Latin America Nuclear Medicine & Radiopharmaceutic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Nuclear Medicine & Radiopharmaceutic Sales in Volume by Country (2018-2023)

8.1.3 Latin America Nuclear Medicine & Radiopharmaceutic Sales in Value by Country (2018-2023)

8.2 Latin America Nuclear Medicine & Radiopharmaceutic Forecasted Market Size by Country

8.2.1 Latin America Nuclear Medicine & Radiopharmaceutic Sales in Volume by Country (2024-2029)

8.2.2 Latin America Nuclear Medicine & Radiopharmaceutic Sales in Value by Country (2024-2029)

9 Middle East and Africa Nuclear Medicine & Radiopharmaceutic by Country

9.1 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Historic Market Size by Country

9.1.1 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Forecasted Market Size by Country

9.2.1 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 GE Healthcare

10.1.1 GE Healthcare Company Information

10.1.2 GE Healthcare Introduction and Business Overview

10.1.3 GE Healthcare Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2018-2023)

10.1.4 GE Healthcare Nuclear Medicine & Radiopharmaceutic Products Offered

10.1.5 GE Healthcare Recent Development

10.2 Bracco Imaging

10.2.1 Bracco Imaging Company Information

10.2.2 Bracco Imaging Introduction and Business Overview

10.2.3 Bracco Imaging Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Bracco Imaging Nuclear Medicine & Radiopharmaceutic Products Offered

10.2.5 Bracco Imaging Recent Development

10.3 Mallinckrodt

10.3.1 Mallinckrodt Company Information

10.3.2 Mallinckrodt Introduction and Business Overview

10.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Mallinckrodt Nuclear Medicine & Radiopharmaceutic Products Offered

10.3.5 Mallinckrodt Recent Development

10.4 Lantheus Medical Imaging

10.4.1 Lantheus Medical Imaging Company Information

10.4.2 Lantheus Medical Imaging Introduction and Business Overview

10.4.3 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Products Offered

10.4.5 Lantheus Medical Imaging Recent Development

10.5 Bayer

10.5.1 Bayer Company Information

10.5.2 Bayer Introduction and Business Overview

10.5.3 Bayer Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Bayer Nuclear Medicine & Radiopharmaceutic Products Offered

10.5.5 Bayer Recent Development

10.6 Jubilant Pharma

10.6.1 Jubilant Pharma Company Information

10.6.2 Jubilant Pharma Introduction and Business Overview

10.6.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Products Offered

10.6.5 Jubilant Pharma Recent Development

10.7 Nordion

10.7.1 Nordion Company Information

10.7.2 Nordion Introduction and Business Overview

10.7.3 Nordion Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Nordion Nuclear Medicine & Radiopharmaceutic Products Offered

10.7.5 Nordion Recent Development

10.8 Eli Lilly

10.8.1 Eli Lilly Company Information

10.8.2 Eli Lilly Introduction and Business Overview

10.8.3 Eli Lilly Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Eli Lilly Nuclear Medicine & Radiopharmaceutic Products Offered

10.8.5 Eli Lilly Recent Development

10.9 SIEMENS

10.9.1 SIEMENS Company Information

10.9.2 SIEMENS Introduction and Business Overview

10.9.3 SIEMENS Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2018-2023)

10.9.4 SIEMENS Nuclear Medicine & Radiopharmaceutic Products Offered

10.9.5 SIEMENS Recent Development

10.10 China Isotope & Radiation

10.10.1 China Isotope & Radiation Company Information

10.10.2 China Isotope & Radiation Introduction and Business Overview

10.10.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2018-2023)

10.10.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Products Offered

10.10.5 China Isotope & Radiation Recent Development

10.11 Yantai Dongcheng Biochemicals

10.11.1 Yantai Dongcheng Biochemicals Company Information

10.11.2 Yantai Dongcheng Biochemicals Introduction and Business Overview

10.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2018-2023)

10.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Products Offered

10.11.5 Yantai Dongcheng Biochemicals Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Nuclear Medicine & Radiopharmaceutic Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Nuclear Medicine & Radiopharmaceutic Industrial Chain Analysis

11.4 Nuclear Medicine & Radiopharmaceutic Market Dynamics

11.4.1 Nuclear Medicine & Radiopharmaceutic Industry Trends

11.4.2 Nuclear Medicine & Radiopharmaceutic Market Drivers

11.4.3 Nuclear Medicine & Radiopharmaceutic Market Challenges

11.4.4 Nuclear Medicine & Radiopharmaceutic Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Nuclear Medicine & Radiopharmaceutic Distributors

12.3 Nuclear Medicine & Radiopharmaceutic Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

GE Healthcare

Bracco Imaging

Mallinckrodt plc

Lantheus Medical Imaging

China Isotope & Radiation

Yantai Dongcheng Biochemicals

List of Tables

Table 1. Major Company of Tc-99

Table 2. Major Company of I-123/131

Table 3. Major Company of In-111

Table 4. Major Company of Xe-133

Table 5. Major Company of Th-201

Table 6. Major Company of Ga-67

Table 7. Major Company of Other

Table 8. Global Nuclear Medicine & Radiopharmaceutic Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 9. Global Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (Kiloton)

Table 10. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Type (2018-2023)

Table 11. Global Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (US& Million)

Table 12. Global Nuclear Medicine & Radiopharmaceutic Market Share in Value by Type (2018-2023)

Table 13. Global Nuclear Medicine & Radiopharmaceutic Price by Type (2018-2023) & (US$/Ton)

Table 14. Global Nuclear Medicine & Radiopharmaceutic Sales by Type (2024-2029) & (Kiloton)

Table 15. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Type (2024-2029)

Table 16. Global Nuclear Medicine & Radiopharmaceutic Sales by Type (2024-2029) & (US$ Million)

Table 17. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Type (2024-2029)

Table 18. Global Nuclear Medicine & Radiopharmaceutic Price by Type (2024-2029) & (US$/Ton)

Table 19. North America Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (Kiloton)

Table 20. North America Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (US$ Million)

Table 21. Europe Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) by Type (2018-2023)

Table 22. Europe Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (US$ Million)

Table 23. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) by Type (2018-2023)

Table 24. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (US$ Million)

Table 25. Latin America Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) by Type (2018-2023)

Table 26. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (US$ Million)

Table 27. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) by Type (2018-2023)

Table 28. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2023) & (US$ Million)

Table 29. Global Nuclear Medicine & Radiopharmaceutic Sales by Company (2018-2023) & (Kiloton)

Table 30. Global Nuclear Medicine & Radiopharmaceutic Sales Share by Company (2018-2023)

Table 31. Global Nuclear Medicine & Radiopharmaceutic Revenue by Company (2018-2023) & (US$ Million)

Table 32. Global Nuclear Medicine & Radiopharmaceutic Revenue Share by Company (2018-2023)

Table 33. Global Market Nuclear Medicine & Radiopharmaceutic Price by Company (2018-2023) & (US$/Ton)

Table 34. Global Nuclear Medicine & Radiopharmaceutic Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 35. Global Nuclear Medicine & Radiopharmaceutic Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine & Radiopharmaceutic as of 2022)

Table 37. Date of Key Manufacturers Enter into Nuclear Medicine & Radiopharmaceutic Market

Table 38. Key Manufacturers Nuclear Medicine & Radiopharmaceutic Product Type

Table 39. Mergers & Acquisitions, Expansion Plans

Table 40. Global Nuclear Medicine & Radiopharmaceutic Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 41. Global Nuclear Medicine & Radiopharmaceutic Sales by Region (2018-2023) & (Kiloton)

Table 42. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Region (2018-2023)

Table 43. Global Nuclear Medicine & Radiopharmaceutic Sales by Region (2018-2023) & (US$ Million)

Table 44. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Region (2018-2023)

Table 45. Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

Table 46. Global Nuclear Medicine & Radiopharmaceutic Sales by Region (2024-2029) & (Kiloton)

Table 47. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Region (2024-2029)

Table 48. Global Nuclear Medicine & Radiopharmaceutic Sales by Region (2024-2029) & (US$ Million)

Table 49. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Region (2024-2029)

Table 50. Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2029)

Table 51. Global Nuclear Medicine & Radiopharmaceutic Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 52. Global Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (Kiloton)

Table 53. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Application (2018-2023)

Table 54. Global Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (US$ Million)

Table 55. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Application (2018-2023)

Table 56. Global Nuclear Medicine & Radiopharmaceutic Price by Application (2018-2023) & (US$/Ton)

Table 57. Global Nuclear Medicine & Radiopharmaceutic Sales by Application (2024-2029) & (Kiloton)

Table 58. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Application (2024-2029)

Table 59. Global Nuclear Medicine & Radiopharmaceutic Sales by Application (2024-2029) & (US$ Million)

Table 60. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Application (2024-2029)

Table 61. Global Nuclear Medicine & Radiopharmaceutic Price by Application (2024-2029) & (US$/Ton)

Table 62. North America Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) (Kiloton)

Table 63. North America Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (US$ Million)

Table 64. Europe Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) (Kiloton)

Table 65. Europe Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (US$ Million)

Table 66. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) (Kiloton)

Table 67. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (US$ Million)

Table 68. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) (Kiloton)

Table 69. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (US$ Million)

Table 70. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) (Kiloton)

Table 71. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2023) & (US$ Million)

Table 72. North America Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (Kiloton)

Table 73. North America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Country (2018-2023)

Table 74. North America Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (US$ Million)

Table 75. North America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Country (2018-2023)

Table 76. North America Nuclear Medicine & Radiopharmaceutic Sales by Country (2024-2029) & (Kiloton)

Table 77. North America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Country (2024-2029)

Table 78. North America Nuclear Medicine & Radiopharmaceutic Sales by Country (2024-2029) & (US$ Million)

Table 79. North America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Country (2024-2029)

Table 80. Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (Kiloton)

Table 81. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Country (2018-2023)

Table 82. Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (US$ Million)

Table 83. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Country (2018-2023)

Table 84. Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2024-2029) & (Kiloton)

Table 85. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Country (2024-2029)

Table 86. Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2024-2029) & (US$ Million)

Table 87. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Country (2024-2029)

Table 88. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales by Region (2018-2023) & (Kiloton)

Table 89. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Region (2018-2023)

Table 90. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales by Region (2018-2023) & (US$ Million)

Table 91. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Region (2018-2023)

Table 92. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales by Region (2024-2029) & (Kiloton)

Table 93. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Region (2024-2029)

Table 94. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales by Region (2024-2029) & (US$ Million)

Table 95. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Region (2024-2029)

Table 96. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (Kiloton)

Table 97. Latin America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Country (2018-2023)

Table 98. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (US$ Million)

Table 99. Latin America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Country (2018-2023)

Table 100. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Country (2024-2029) & (Kiloton)

Table 101. Latin America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Country (2024-2029)

Table 102. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Country (2024-2029) & (US$ Million)

Table 103. Latin America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Country (2024-2029)

Table 104. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (Kiloton)

Table 105. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Country (2018-2023)

Table 106. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2018-2023) & (US$ Million)

Table 107. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Country (2018-2023)

Table 108. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2024-2029) & (Kiloton)

Table 109. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Country (2024-2029)

Table 110. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2024-2029) & (US$ Million)

Table 111. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Country (2024-2029)

Table 112. GE Healthcare Company Information

Table 113. GE Healthcare Introduction and Business Overview

Table 114. GE Healthcare Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2023)

Table 115. GE Healthcare Nuclear Medicine & Radiopharmaceutic Product

Table 116. GE Healthcare Recent Development

Table 117. Bracco Imaging Company Information

Table 118. Bracco Imaging Introduction and Business Overview

Table 119. Bracco Imaging Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2023)

Table 120. Bracco Imaging Nuclear Medicine & Radiopharmaceutic Product

Table 121. Bracco Imaging Recent Development

Table 122. Mallinckrodt Company Information

Table 123. Mallinckrodt Introduction and Business Overview

Table 124. Mallinckrodt Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2023)

Table 125. Mallinckrodt Nuclear Medicine & Radiopharmaceutic Product

Table 126. Mallinckrodt Recent Development

Table 127. Lantheus Medical Imaging Company Information

Table 128. Lantheus Medical Imaging Introduction and Business Overview

Table 129. Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2023)

Table 130. Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Product

Table 131. Lantheus Medical Imaging Recent Development

Table 132. Bayer Company Information

Table 133. Bayer Introduction and Business Overview

Table 134. Bayer Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2023)

Table 135. Bayer Nuclear Medicine & Radiopharmaceutic Product

Table 136. Bayer Recent Development

Table 137. Jubilant Pharma Company Information

Table 138. Jubilant Pharma Introduction and Business Overview

Table 139. Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2023)

Table 140. Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Product

Table 141. Jubilant Pharma Recent Development

Table 142. Nordion Company Information

Table 143. Nordion Introduction and Business Overview

Table 144. Nordion Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2023)

Table 145. Nordion Nuclear Medicine & Radiopharmaceutic Product

Table 146. Nordion Recent Development

Table 147. Eli Lilly Company Information

Table 148. Eli Lilly Introduction and Business Overview

Table 149. Eli Lilly Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2023)

Table 150. Eli Lilly Nuclear Medicine & Radiopharmaceutic Product

Table 151. Eli Lilly Recent Development

Table 152. SIEMENS Company Information

Table 153. SIEMENS Introduction and Business Overview

Table 154. SIEMENS Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2023)

Table 155. SIEMENS Nuclear Medicine & Radiopharmaceutic Product

Table 156. SIEMENS Recent Development

Table 157. China Isotope & Radiation Company Information

Table 158. China Isotope & Radiation Introduction and Business Overview

Table 159. China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2023)

Table 160. China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Product

Table 161. China Isotope & Radiation Recent Development

Table 162. Yantai Dongcheng Biochemicals Company Information

Table 163. Yantai Dongcheng Biochemicals Introduction and Business Overview

Table 164. Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2023)

Table 165. Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Product

Table 166. Yantai Dongcheng Biochemicals Recent Development

Table 167. Key Raw Materials Lists

Table 168. Raw Materials Key Suppliers Lists

Table 169. Nuclear Medicine & Radiopharmaceutic Market Trends

Table 170. Nuclear Medicine & Radiopharmaceutic Market Drivers

Table 171. Nuclear Medicine & Radiopharmaceutic Market Challenges

Table 172. Nuclear Medicine & Radiopharmaceutic Market Restraints

Table 173. Nuclear Medicine & Radiopharmaceutic Distributors List

Table 174. Nuclear Medicine & Radiopharmaceutic Downstream Customers

Table 175. Research Programs/Design for This Report

Table 176. Key Data Information from Secondary Sources

Table 177. Key Data Information from Primary Sources

List of Figures

Figure 1. Nuclear Medicine & Radiopharmaceutic Product Picture

Figure 2. Global Nuclear Medicine & Radiopharmaceutic Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Nuclear Medicine & Radiopharmaceutic Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Nuclear Medicine & Radiopharmaceutic Sales Status and Outlook (2018-2029) & (Kiloton)

Figure 5. Product Picture of Tc-99

Figure 6. Global Tc-99 Sales YoY Growth (2018-2029) & (Kiloton)

Figure 7. Product Picture of I-123/131

Figure 8. Global I-123/131 Sales YoY Growth (2018-2029) & (Kiloton)

Figure 9. Product Picture of In-111

Figure 10. Global In-111 Sales YoY Growth (2018-2029) & (Kiloton)

Figure 11. Product Picture of Xe-133

Figure 12. Global Xe-133 Sales YoY Growth (2018-2029) & (Kiloton)

Figure 13. Product Picture of Th-201

Figure 14. Global Th-201 Sales YoY Growth (2018-2029) & (Kiloton)

Figure 15. Product Picture of Ga-67

Figure 16. Global Ga-67 Sales YoY Growth (2018-2029) & (Kiloton)

Figure 17. Product Picture of Other

Figure 18. Global Other Sales YoY Growth (2018-2029) & (Kiloton)

Figure 19. Global Nuclear Medicine & Radiopharmaceutic Sales by Type (2018-2029) & (US$ Million)

Figure 20. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type in 2022 & 2029

Figure 21. North America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Type in 2022

Figure 22. North America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Type in 2022

Figure 23. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Type in 2022

Figure 24. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Type in 2022

Figure 25. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Type in 2022

Figure 26. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Type in 2022

Figure 27. Latin America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Type in 2022

Figure 28. Latin America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Type in 2022

Figure 29. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Type in 2022

Figure 30. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Type in 2022

Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Medicine & Radiopharmaceutic Sales in 2022

Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Medicine & Radiopharmaceutic Revenue in 2022

Figure 33. Nuclear Medicine & Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 34. Product Picture of Diagnostic

Figure 35. Global Diagnostic Sales YoY Growth (2018-2029) & (Kiloton)

Figure 36. Product Picture of Therapeutic

Figure 37. Global Therapeutic Sales YoY Growth (2018-2029) & (Kiloton)

Figure 38. Global Nuclear Medicine & Radiopharmaceutic Sales by Application (2018-2029) & (US$ Million)

Figure 39. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application in 2022 & 2029

Figure 40. North America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Application in 2022

Figure 41. North America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Application in 2022

Figure 42. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Application in 2022

Figure 43. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Application in 2022

Figure 44. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Application in 2022

Figure 45. Asia-Pacific Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Application in 2022

Figure 46. Latin America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Volume by Application in 2022

Figure 47. Latin America Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Application in 2022

Figure 48. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share in Value by Application in 2022

Figure 49. Key Raw Materials Price

Figure 50. Nuclear Medicine & Radiopharmaceutic Manufacturing Cost Structure

Figure 51. Nuclear Medicine & Radiopharmaceutic Industrial Chain Analysis

Figure 52. Channels of Distribution

Figure 53. Distributors Profiles

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Clean Coal Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24Q7833

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Low Iron Solar Glass Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20R6855

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Geosteering Drilling Technology Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-15Z12695

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global EOR Surfactant Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8142

Fri May 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions